Rees DC, Kilinc Y, Unal S, Dampier C, Pace BS, Kaya B, et al. A randomized, placebo-controlled, double-blind trial of canakinumab in children and young adults with sickle cell anemia. Blood. 2022;139(17):2642-52. https://ashpublications.org/blood/article-abstract/139/17/2642/484189/A-randomized-placebo-controlled-double-blind-trial?redirectedFrom=fulltext
A randomized, placebo-controlled, double-blind trial of canakinumab in children and young adults with sickle cell anemia.
By Peter Matlawa|2023-04-13T10:46:44+02:00April 13, 2023|2022: April to June|Comments Off on A randomized, placebo-controlled, double-blind trial of canakinumab in children and young adults with sickle cell anemia.
Share This Story, Choose Your Platform!
About the Author: Peter Matlawa
Related Posts
Antimicrobial susceptibility and genomic profiling of Salmonella enterica from bloodstream infections at a tertiary referral hospital in Lusaka, Zambia, 2018-2019.